LH
LABCORP HOLDINGS INC.
NYSE: LH · Burlington, NC · Healthcare
$296.77+5.75 (+1.98%)Closed
Market Cap$24.42B
Cash$981.1Mmost recent
Runwayprofitable
P/E (TTM)28.4EPS $10.46
52-Wk Range$244.69 – $296.77
Avg Volume676.9K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$296.77+44.7%
Pipeline
Drug candidates sponsored by LABCORP · ClinicalTrials.gov
| Phase | Drug / Candidate | Indications | Status | Next Completion | Trials | |
|---|---|---|---|---|---|---|
| N/A | Unnamed | Oncology+4 more | Suspended | 2022-08-03past | 1 | |
| N/A | Unnamed | Lung Cancer+12 more | Completed | 2024-12-31past | 1 |
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for LH. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.